Method of encapsulating biologically active agents within erythr

Details Method of encapsulating biologically active agents within erythr Method of encapsulating biologically active agents within erythr

1998-05-01

2000-10-31

Jones, Dwayne C.

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Animal or plant cell

424 931, 424 933, 424 937, 435 2, A01N 6300

Patent

active

061398365

ABSTRACT:
A method and apparatus for the encapsulation of biologically active agents in red blood cells (RBCS) is disclosed. The method is characterized in that lysed and partially lysed RBCs are concentrated prior to the introduction of the biologically active agent. The resultant carrier RBCs are stable for an extended period of time under physiological conditions and can be used for the systemic or targeted delivery of therapeutically effective amounts of one or more biologically active agents to a patient.

REFERENCES:
patent: 4224313 (1980-09-01), Zimmermann et al.
patent: 4269826 (1981-05-01), Zimmermann et al.
patent: 4289756 (1981-09-01), Zimmermann et al.
patent: 4327710 (1982-05-01), DeLoach et al.
patent: 4420559 (1983-12-01), Zimmermann
patent: 4478824 (1984-10-01), Franco et al.
patent: 4652449 (1987-03-01), Ropars et al.
patent: 4931276 (1990-06-01), Franco et al.
patent: 5589389 (1996-12-01), Pages et al.
Magnani et al., "Erythrocyte Engineering for Drug Delivery and Targeting," Biotechnol. Appl. Biochem., 28(1):1-6 (Aug. 1998).
Chiarantini, L., et al., "Modulated Red Blood Cell Survival by Membrane Protein Clustering," Molecular and Cellular Biochemistry, 144:53-59, 1995.
Franco, R., et al., "Effect of Inositol Hexaphosphate on the Transient Behavior o Red Cells Following a DMSO-Induced Osmotic Pulse," Journal of Cellular Physiology, 129:221-229 (1986).
Franco, R., et al., "Incorporation of Inositol Hexaphosphate into Red Blood Cells Mediated by Dimethyl Sulfoxide," Life Sciences, 32:2763-2768 (1983).
Franco, R., et al., "Preparation of Low-Affinity Red Cells with Dimethylsulfoxide-Mediated Inositol Hexaphosphate Incorporation: Hemoglobin and ATP Recovery Using a Continuous-Flow Method," American Journal of Hematology, 17:393-400 (1984).
Heubusch, P., et al., "The Osmotic Response of Human Erythrocytes and the Membrane Cytoskeleton," Journal of Cellular Physiology, 122:266-272 (1985).
Jain, S., et al., "Magnetically Responsive Diclofenac Sodium-Loaded Erythrocytes: Preparation and In Vitro Characterization," Journal of Microencapsulation, 11:141-151 (1994).
Magnani, M., et al., "Targeting Antiretroviral Nucleoside Analogues in Phosphorylated Form to Macrophages: In Vitro and In Vivo Studies," Proc. Natl. Acad. Sci. USA, 89:6477-6481 (1992).
Magnani, M., et al., "Targeting Dexamethasone to Macrophages," Drug Delivery, 2:151-155 (1995).
Rechsteiner, M., "Uptake of Proteins by Red Blood Cells," Exptl. Cell Res., 93:487-492 (1975).
Ropars, C., et al., "Resealed Red Blood Cells as a New Blood Transfusion Product," Biblthca haemat., 51:82-91 (Karger, Basil 1985).
Talwar, N., et al., "Erythrocytes as Carriers of Primaquine-Preparation: Characterization and Evaluation," Journal of Controlled Release, 20:133-141 (1992).
European Search Report for EP 97830211, dated Oct. 20, 1997, 4 pages.

Affiliated with

Also associated with

Rating

Method of encapsulating biologically active agents within erythr does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of encapsulating biologically active agents within erythr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of encapsulating biologically active agents within erythr will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2047974